NCT01232465

Brief Summary

Sperm DNA integrity will be measured via the Toluidine Blue Assay (TBA) for patients undergoing In Vitro Fertilization (IVF); the study will determine correlations, if any, between IVF success and sperm DNA integrity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
420

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2010

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2010

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

October 28, 2010

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 2, 2010

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2013

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2013

Completed
6 months until next milestone

Results Posted

Study results publicly available

March 6, 2014

Completed
Last Updated

April 11, 2014

Status Verified

March 1, 2014

Enrollment Period

2.3 years

First QC Date

October 28, 2010

Results QC Date

January 21, 2014

Last Update Submit

March 14, 2014

Conditions

Keywords

sperm DNA integrityToluidine blue assay (TBA)IVF outcome

Outcome Measures

Primary Outcomes (1)

  • Pregnancy

    detemining whether the sperm sample (tested for DNA integrity) used to insemenate IVF retrieved eggs, results in a live birth

    9 months

Study Arms (2)

IVF

those individuals undergoing conventional IVF to inseminate their retrieved eggs

ICSI

those individuals whose eggs were fertilized via intracytoplasmic sperm injection (ICSI)

Eligibility Criteria

Sexmale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

couples undergoing IVF treatement at the Center for Human Reproduction, North Shore University Hospital, Manhasset NY

You may qualify if:

  • couple undergoing IVF at the Center for Human Reproduction
  • sperm sample given from partner (not a donor)

You may not qualify if:

  • low sperm concentration (\<5 million/cc)
  • using a donor sample

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Center for Human Reproduction

Manhasset, New York, 11303, United States

Location

Related Publications (12)

  • Andreetta AM, Stockert JC, Barrera C. A simple method to detect sperm chromatin abnormalities: cytochemical mechanism and possible value in predicting semen quality in assisted reproductive procedures. Int J Androl. 1995 Jun;18 Suppl 1:23-8. doi: 10.1111/j.1365-2605.1995.tb00634.x.

    PMID: 7558384BACKGROUND
  • Erenpreisa J, Erenpreiss J, Freivalds T, Slaidina M, Krampe R, Butikova J, Ivanov A, Pjanova D. Toluidine blue test for sperm DNA integrity and elaboration of image cytometry algorithm. Cytometry A. 2003 Mar;52(1):19-27. doi: 10.1002/cyto.a.10015.

    PMID: 12596248BACKGROUND
  • Erenpreiss J, Bars J, Lipatnikova V, Erenpreisa J, Zalkalns J. Comparative study of cytochemical tests for sperm chromatin integrity. J Androl. 2001 Jan-Feb;22(1):45-53.

    PMID: 11191087BACKGROUND
  • Erenpreiss J, Jepson K, Giwercman A, Tsarev I, Erenpreisa J, Spano M. Toluidine blue cytometry test for sperm DNA conformation: comparison with the flow cytometric sperm chromatin structure and TUNEL assays. Hum Reprod. 2004 Oct;19(10):2277-82. doi: 10.1093/humrep/deh417. Epub 2004 Jul 22.

    PMID: 15271869BACKGROUND
  • Schlegel PN, Paduch DA. Yet another test of sperm chromatin structure. Fertil Steril. 2005 Oct;84(4):854-9. doi: 10.1016/j.fertnstert.2005.04.050.

    PMID: 16213834BACKGROUND
  • Collins JA, Barnhart KT, Schlegel PN. Do sperm DNA integrity tests predict pregnancy with in vitro fertilization? Fertil Steril. 2008 Apr;89(4):823-31. doi: 10.1016/j.fertnstert.2007.04.055. Epub 2007 Jul 20.

    PMID: 17644094BACKGROUND
  • Simon L, Brunborg G, Stevenson M, Lutton D, McManus J, Lewis SE. Clinical significance of sperm DNA damage in assisted reproduction outcome. Hum Reprod. 2010 Jul;25(7):1594-608. doi: 10.1093/humrep/deq103. Epub 2010 May 6.

    PMID: 20447937BACKGROUND
  • Tarozzi N, Bizzaro D, Flamigni C, Borini A. Clinical relevance of sperm DNA damage in assisted reproduction. Reprod Biomed Online. 2007 Jun;14(6):746-57. doi: 10.1016/s1472-6483(10)60678-5.

    PMID: 17579991BACKGROUND
  • Zini A, Libman J. Sperm DNA damage: clinical significance in the era of assisted reproduction. CMAJ. 2006 Aug 29;175(5):495-500. doi: 10.1503/cmaj.060218.

    PMID: 16940270BACKGROUND
  • Sharma RK, Said T, Agarwal A. Sperm DNA damage and its clinical relevance in assessing reproductive outcome. Asian J Androl. 2004 Jun;6(2):139-48.

    PMID: 15154089BACKGROUND
  • Speyer BE, Pizzey AR, Ranieri M, Joshi R, Delhanty JD, Serhal P. Fall in implantation rates following ICSI with sperm with high DNA fragmentation. Hum Reprod. 2010 Jul;25(7):1609-18. doi: 10.1093/humrep/deq116. Epub 2010 May 22.

    PMID: 20495207BACKGROUND
  • Tsarev I, Bungum M, Giwercman A, Erenpreisa J, Ebessen T, Ernst E, Erenpreiss J. Evaluation of male fertility potential by Toluidine Blue test for sperm chromatin structure assessment. Hum Reprod. 2009 Jul;24(7):1569-74. doi: 10.1093/humrep/dep068. Epub 2009 Mar 21.

    PMID: 19304993BACKGROUND

Biospecimen

Retention: SAMPLES WITHOUT DNA

slide smears will be kept to observe overall DNA integrity of sperm sample

MeSH Terms

Conditions

Infertility, MaleAbortion, Habitual

Condition Hierarchy (Ancestors)

Genital Diseases, MaleGenital DiseasesUrogenital DiseasesInfertilityMale Urogenital DiseasesAbortion, SpontaneousPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy Complications

Results Point of Contact

Title
Dennis Marchesi
Organization
North Shore

Study Officials

  • Avner E Hershlag, MD

    Center for Human Reproduction

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 28, 2010

First Posted

November 2, 2010

Study Start

October 1, 2010

Primary Completion

February 1, 2013

Study Completion

September 1, 2013

Last Updated

April 11, 2014

Results First Posted

March 6, 2014

Record last verified: 2014-03

Locations